ROCKET PHARMACEUTICALS, INC.·4

Aug 20, 4:26 PM ET

Wilson Martin 4

4 · ROCKET PHARMACEUTICALS, INC. · Filed Aug 20, 2024

Insider Transaction Report

Form 4
Period: 2024-08-16
Wilson Martin
General Counsel
Transactions
  • Sale

    Common Stock

    2024-08-16$18.50/sh1,027$19,00464,735 total
Footnotes (1)
  • [F1]The shares of common stock were sold by the Reporting Person in order to pay tax withholding obligations in connection with the vesting of RSUs.

Documents

1 file
  • 4
    form4.xmlPrimary

    FORM 4